Supportive Medicines Procurement Exercise - CM EMI 20 1100
key details
| Value | £1 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | East Midlands, East of England, London, North East, North West, Scotland, South East, South West, Wales, West Midlands, Yorkshire and the Humber, Northern Ireland |
| Deadline | 12 Jul 2020 |
| Contract start | 21 Jul 2020 |
| Contract end | 31 Aug 2020 |
| Procedure | limited |
| SME suitable | Yes |
| OCID | ocds-b5fd17-bdca9199-5124-4303-a1ad-d7924b375635 |
Awards (9)
This procurement was awarded to 9 suppliers. Values shown are per-award; the notice total is £1.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Altan Pharma Ltd shared | £3,869,091 | 23 Jul 2020 | active |
| Aspen Pharma Ireland Limited shared | £3,869,091 | 23 Jul 2020 | active |
| Baxter Healthcare Ltd shared | £3,869,091 | 23 Jul 2020 | active |
| Durbin PLC shared | £3,869,091 | 23 Jul 2020 | active |
| Martindale Pharma shared | £3,869,091 | 23 Jul 2020 | active |
| Mawdsley-Brooks & Co Ltd shared | £3,869,091 | 23 Jul 2020 | active |
| Merck Sharp & Dohme (MSD) shared | £3,869,091 | 23 Jul 2020 | active |
| Neon Healthcare Ltd shared | £3,869,091 | 23 Jul 2020 | active |
| Zentiva Pharma UK Ltd shared | £3,869,091 | 23 Jul 2020 | active |
description
Procurement exercise to secure stocks of Intensive Treatment Unit medicines, Antibiotic Medicines and End of Life Care Medicines
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 25 Nov 2020 | Award (award) | · | 05136092-71e5-4478-bc8b-42979f27b498-395875 |
more from Department of Health and Social Care (DHSC)
- Hugh's Report-MH Impact of Life-threatening Child Illness on families 2026 · £216,540 · 26 Jun 2026
- D&B + API Interface · £542,011 · 25 Jun 2026
- NCMP IT System - Discovery Phase · £183,768 · 19 May 2026
- DHSC: CL Temporary Executive Support to the Permanent Secretary - JW · £17,702 · 19 May 2026
- DHSC: GO: 26/27 - WIST: DAC hosting on CSP · £168,000 · 2 Apr 2026
- RM1043.8-1-DEPARTMENT OF HEALTH AND SOCIAL CARE - Find Public Health Data · £1,251,360 · 2 Apr 2026
- DHSC:NHST: National GP Engagement on Health Data · £267,000 · 31 Mar 2026
- DHSC: CL FGO Contingent Labour SD Extension · £133,710 · 31 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.